Skip to main content

Table 3 Survivin, XIAP and XAF1 immunoreactivity.

From: Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma

   Survivin XIAP XAF1
  IHC score* n (%) n (%) n (%)
HCC Negative -   7 17,5% 23 57,5%
  Low 22 55,0% 23 57,5% 17 42,5%
  High 18 45,0% 10 25,0% -  
Adjacent liver# Negative -   10 25,0% 21 52,5%
  Low 2 5,0% 19 47,5% 19 47,5%
  High 38 95,0% 11 27,5% -  
Non-adjacent liver# Negative -   12 30,0% 25 62,5%
  Low 1 2,5% 18 45,0% 15 37,5%
  High 39 97,5% 10 25,0% -  
  1. The number (n) and the percentage of patients (%) in each IHC category are indicated.
  2. *Negative (score 0), Low (score 1–6) and High (score 7–12).
  3. #Adjacent liver: liver parenchyma at less than 1 cm from the tumor; non-adjacent liver: liver parenchyma at more than 3 cm from tumor.